Within the immunosuppressive ocular microenvironment, there are constitutively present the immunomodulating neuropeptides alpha-melanocyte stimulating hormone (α-MSH) and neuropeptide Y (NPY) that promote suppressor functionality in macrophages. In this study, we examined the possibility that α-MSH and NPY modulate phagocytic activity in macrophages. The macrophages treated with α-MSH and NPY were significantly suppressed in their capacity to phagocytize unopsonized Escherichia coli and Staphylococcus aureus bioparticles, but not antibody-opsonized bioparticles. The neuropeptides significantly suppressed phagolysosome activation, and the FcR-associated generation of reactive oxidative species as well. This suppression corresponds to neuropeptide modulation of macrophage functionality within the ocular microenvironment to suppress the activation of immunogenic inflammation.
Introduction
The neuropeptides alpha-melanocyte stimulating hormone (α-MSH) and neuropeptide Y (NPY) are produced by retinal pigment epithelium (RPE) (Kawanaka and Taylor, 2010) , the monolayer of pigmented cells at the back of eye upon which the neural retina rests. This intact RPE monolayer induces myeloid suppressor cell-like activities in macrophages and retinal microglial cells that are dependent on the RPE producing both α-MSH and NPY (Kawanaka and Taylor, 2010) . These neuropeptides with other immunomodulating factors are constitutively produced within the ocular microenvironment and are part of the mechanisms of ocular immune privilege (Taylor, 2009 ). Both α-MSH and NPY are considered immunomodulating neuropeptides that can influence macrophage functionality and responses to signals of innate immunity (Dimitrijević et al., 2005; Taylor, 2005; Lam et al., 2006; Li and Taylor, 2008; Zhou et al., 2008) . Together they suppress proinflammatory signals and promote an alternative activation of macrophages.
In activated macrophages, α-MSH is a suppressor of Toll-like receptor (TLR) and urate crystal stimulated inflammatory activity (Sarkar et al., 2003; Taylor, 2005; Getting et al., 2006; Li and Taylor, 2008) . Treatment of the stimulated macrophages with α-MSH suppresses NF-κB and p38MAPK activation (Manna and Aggarwal, 1998; Brzoska et al., 1999; Ichiyama et al., 1999; Yoon et al., 2003; Li and Taylor, 2008) . This suppression of the TLR4 pathways is through α-MSH mediated binding of IRAK-M to IRAK-1, and suppression of both the TLR and urate crystal stimulated activation of p38MAPK is through α-MSH activation cAMP dependent PKA (Yoon et al., 2003; Li and Taylor, 2008) . In addition, α-MSH alternatively activates macrophages and dendritic cells and promotes suppressive and tolerogenic functions when the cells act as antigen presenting cells (APC) (Luger et al., 1999; Taylor, 2005; Lau and Taylor, 2009 ). This has suggested that α-MSH is an immunosuppressive neuropeptide that promotes anti-inflammatory activity and tolerance.
The effects of NPY on macrophages are not as easily characterized and maybe related to age-associated changes in receptor expression (Dimitrijević et al., 2005; Bedoui et al., 2007; Dimitrijevic and Stanojevic, 2011) . NPY suppress macrophage migration, but if the macrophages are from aging animals, there is no effect (De la Fuente et al., 2000; Medina et al., 2000; Nave et al., 2004) . In addition, NPY suppresses phagocytosis of pathogens, and the production of TNF-α by pathogen-stimulated macrophages (Ahmed et al., 2001; Dimitrijević et al., 2005; Puerto et al., 2005; Stanojevic et al., 2007) . However, NPY can stimulate IL-1β production in concanavalin A-stimulated macrophages, and augment phagocytosis of innate substances like opsonized-latex beads, and potentiate reactive oxygen species generation (De la Fuente et al., 2001; Puerto et al., 2005; Stanojevic et al., 2007) . While NPY may signal a proinflammatory response in macrophages, and promote APC functionality, NPY suppresses the activation of effector T cells (Prod'homme et al., 2006) . Therefore, the effects of NPY on macrophages appear to be more influenced by the microenvironment, the stimulating agents, and aging than the effects of α-MSH.
Soluble factors from healthy RPE monolayer induce peripheral resting macrophages to co-express the arginine substrate enzymes nitric oxide synthase 2 (NOS2) and Arginase 1 (Arg1) (Kawanaka and Taylor, 2010) . These treated macrophages express myeloid suppressor cell like characteristics, generate nitric oxide, and promote T Journal of Neuroimmunology 260 (2013) 9-16 
